tradingkey.logo
tradingkey.logo
Search

Cocrystal Pharma Inc

COCP
Add to Watchlist
0.820USD
-0.044-5.15%
Close 07-31 16:00ETQuotes delayed by 15 min
11.31MMarket Cap
LossP/E TTM

COCP Financials

See Cocrystal Pharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cocrystal Pharma Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.17/-0.15
Revenue / Forecast
225.00K/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.78
54.66%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
26.26%-0.17
45.29%-0.18
61.60%-0.19
61.54%-0.20
41.84%-0.23
26.50%-0.32
-18.34%-0.49
-26.88%-0.53
38.98%-0.39
20.98%-0.44
---0.41
---0.41
---0.64
---0.55
----
----
----
----
----
----
Revenue
--225.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
Net Profit
0.09%-2.30M
25.72%-2.43M
58.51%-2.05M
61.54%-2.06M
41.84%-2.30M
26.84%-3.27M
-18.58%-4.94M
-28.25%-5.34M
23.76%-3.96M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-22.14%-4.50M
-44.63%-5.70M
-539.31%-24.43M
-53.69%-4.21M
-146.82%-3.69M
-47.60%-3.94M
-9.33%-3.82M
Net Margin
---1021.78%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--0.00%
--0.00%
--0.02%
----
----
----
----
----
----
Revenue
--225.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
Operating profit
-0.64%-2.36M
23.19%-2.48M
58.57%-2.09M
61.31%-2.11M
43.70%-2.34M
42.99%-3.23M
16.56%-5.04M
-25.56%-5.45M
18.65%-4.16M
-25.86%-5.67M
-6.13%-6.04M
-16.14%-4.34M
-21.55%-5.11M
-21.61%-4.50M
-44.04%-5.69M
2.40%-3.74M
-53.58%-4.21M
-152.52%-3.70M
-45.92%-3.95M
-10.96%-3.83M
Net Profit
0.09%-2.30M
25.72%-2.43M
58.51%-2.05M
61.54%-2.06M
41.84%-2.30M
26.84%-3.27M
-18.58%-4.94M
-28.25%-5.34M
23.76%-3.96M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-22.14%-4.50M
-44.63%-5.70M
-539.31%-24.43M
-53.69%-4.21M
-146.82%-3.69M
-47.60%-3.94M
-9.33%-3.82M
Current assets
-32.71%5.94M
-29.76%8.13M
-38.40%8.78M
-65.59%6.76M
-63.96%8.83M
-60.19%11.58M
-55.73%14.26M
-45.02%19.66M
-34.22%24.49M
-27.59%29.09M
-28.27%32.20M
-30.69%35.76M
-32.79%37.24M
-32.27%40.18M
-28.10%44.90M
-23.38%51.60M
64.43%55.40M
74.40%59.32M
89.80%62.44M
234.98%67.34M
Total current liabilities
15.43%2.23M
-8.98%2.21M
-21.97%1.52M
-31.01%1.83M
-18.83%1.93M
-25.57%2.43M
1.25%1.95M
67.23%2.65M
-24.36%2.38M
168.26%3.26M
18.84%1.92M
-43.58%1.59M
101.86%3.15M
-21.29%1.22M
31.84%1.62M
18.24%2.81M
6.93%1.56M
13.77%1.54M
-53.02%1.23M
-19.16%2.38M
Total assets
-30.33%7.43M
-27.82%9.71M
-35.65%10.45M
-60.58%8.51M
-59.85%10.66M
-56.95%13.46M
-50.23%16.23M
-40.54%21.57M
-29.85%26.55M
-23.46%31.26M
-28.55%32.61M
-30.74%36.28M
-49.79%37.84M
-48.56%40.84M
-44.74%45.65M
-40.08%52.38M
39.96%75.37M
46.37%79.39M
55.21%82.60M
115.96%87.42M
Total liabilities
-1.34%3.31M
-14.04%3.38M
-21.33%2.78M
-24.17%3.17M
-15.30%3.35M
-19.32%3.93M
83.47%3.53M
161.93%4.18M
24.87%3.96M
282.95%4.88M
10.70%1.92M
-46.59%1.60M
77.01%3.17M
-30.93%1.27M
9.58%1.74M
12.03%2.99M
-0.06%1.79M
6.10%1.84M
-47.81%1.59M
-22.03%2.67M
Total equity
-43.65%4.12M
-33.52%6.33M
-39.63%7.67M
-69.33%5.33M
-67.66%7.30M
-63.91%9.52M
-58.61%12.70M
-49.86%17.39M
-34.86%22.59M
-33.32%26.38M
-30.11%30.69M
-29.78%34.68M
-52.88%34.67M
-48.98%39.57M
-45.80%43.91M
-41.72%49.39M
41.34%73.58M
47.70%77.55M
61.45%81.01M
128.71%84.75M
Net operating income
20.38%-2.34M
45.06%-1.74M
73.41%-1.36M
41.74%-2.15M
34.73%-2.94M
4.99%-3.16M
-91.09%-5.12M
33.33%-3.70M
-44.74%-4.50M
32.03%-3.33M
69.90%-2.68M
-48.98%-5.55M
20.43%-3.11M
-67.45%-4.89M
-64.87%-8.91M
-41.92%-3.72M
-120.90%-3.91M
-22.72%-2.92M
-76.51%-5.40M
-19.27%-2.62M
Net investment
----
--0.00
---12.00K
--0.00
100.00%0.00
100.00%0.00
--0.00
100.00%0.00
82.22%-8.00K
-391.67%-59.00K
100.00%0.00
---14.00K
---45.00K
-50.00%-12.00K
-1450.00%-62.00K
100.00%0.00
100.00%0.00
-700.00%-8.00K
78.95%-4.00K
88.19%-15.00K
Net financing
----
--1.03M
--4.34M
----
----
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
57242.86%4.00M
-16.67%-7.00K
22.22%-7.00K
36.36%-7.00K
-100.02%-7.00K
-100.29%-6.00K
-100.25%-9.00K
-100.07%-11.00K
82879.55%36.42M

FAQs

What are the current assets of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its current assets were 8.13M, with a year-on-year change of -29.76.

What are the total assets of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its total assets of Cocrystal Pharma Inc were 9.71M, with a year-on-year change of -27.82.

What are the total liabilities of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its total liabilities of Cocrystal Pharma Inc were 3.38M, with a year-on-year change of -14.04.

What is the total equity of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its total equity of Cocrystal Pharma Inc was 6.33M, with a year-on-year change of -33.52.

What is the net operating income of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its net operating income of Cocrystal Pharma Inc was -9.02M, with a year-on-year change of 49.55.

What is the net investment of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its net investment of Cocrystal Pharma Inc was -12.00K, with a year-on-year change of -50.00.

What is the Earnings Per Share (EPS) of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.78, with a year-on-year change of 54.66.

What is the net income of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its net income was -8.83M, with a year-on-year change of 49.55.

What is the Return on Equity (ROE) of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -111.40, with a year-on-year change of -14.26.

What is the Return on Assets (ROA) of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -76.23, with a year-on-year change of 2.63.

What is the operating profit of Cocrystal Pharma Inc?

According to Cocrystal Pharma Inc's FY2025 earnings report, its operating profit was -9.02M, with a year-on-year change of 49.55.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.